Repligen Corporation (RGEN)
NASDAQ: RGEN · Real-Time Price · USD
117.43
-0.86 (-0.73%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Repligen Employees
Repligen had 2,000 employees as of December 31, 2025. The number of employees increased by 222 or 12.49% compared to the previous year.
Employees
2,000
Change (1Y)
222
Growth (1Y)
12.49%
Revenue / Employee
$369,128
Profits / Employee
$24,447
Market Cap
6.62B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2,000 | 222 | 12.49% |
| Dec 31, 2024 | 1,778 | -5 | -0.28% |
| Dec 31, 2023 | 1,783 | -242 | -11.95% |
| Dec 31, 2022 | 2,025 | 173 | 9.34% |
| Dec 31, 2021 | 1,852 | 724 | 64.18% |
| Dec 31, 2020 | 1,128 | 367 | 48.23% |
| Dec 31, 2019 | 761 | 213 | 38.87% |
| Dec 31, 2018 | 548 | 72 | 15.13% |
| Dec 31, 2017 | 476 | 240 | 101.69% |
| Dec 31, 2016 | 236 | 68 | 40.48% |
| Dec 31, 2015 | 168 | 32 | 23.53% |
| Dec 31, 2014 | 136 | 20 | 17.24% |
| Dec 31, 2013 | 116 | -4 | -3.33% |
| Dec 31, 2012 | 120 | -17 | -12.41% |
| Dec 31, 2011 | 137 | 69 | 101.47% |
| May 6, 2010 | 68 | -1 | -1.45% |
| May 31, 2009 | 69 | 13 | 23.21% |
| May 27, 2008 | 56 | 11 | 24.44% |
| Jun 30, 2007 | 45 | 2 | 4.65% |
| Jun 6, 2006 | 43 | 6 | 16.22% |
| Jun 7, 2005 | 37 | -3 | -7.50% |
| Jun 7, 2004 | 40 | -4 | -9.09% |
| May 15, 2003 | 44 | 5 | 12.82% |
| May 15, 2002 | 39 | -1 | -2.50% |
| May 15, 2001 | 40 | 13 | 48.15% |
| May 15, 2000 | 27 | 3 | 12.50% |
| May 15, 1999 | 24 | 0 | - |
| May 29, 1998 | 24 | 4 | 20.00% |
| May 15, 1997 | 20 | 5 | 33.33% |
| Jun 14, 1996 | 15 | -89 | -85.58% |
| Mar 31, 1995 | 104 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| Baxter International | 37,500 |
| Solventum | 20,584 |
| Teleflex | 15,500 |
| The Cooper Companies | 15,000 |
| AptarGroup | 14,000 |
| Avantor | 13,500 |
| Bausch + Lomb | 13,000 |
| Envista Holdings | 12,000 |
RGEN News
- 6 days ago - Repligen to Report First Quarter 2026 Financial Results - GlobeNewsWire
- 11 days ago - Repligen Opens European Training & Innovation Center in Breda, Expanding Global Customer Support Network - GlobeNewsWire
- 5 weeks ago - Repligen Transcript: 2026 KeyBanc Capital Markets Healthcare Forum - Transcripts
- 7 weeks ago - Repligen Transcript: Leerink Global Healthcare Conference 2026 - Transcripts
- 2 months ago - Repligen Earnings Call Transcript: Q4 2025 - Transcripts
- 2 months ago - Repligen Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Financial Guidance - GlobeNewsWire
- 2 months ago - Repligen to Report Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
- 3 months ago - Repligen Transcript: 44th Annual J.P. Morgan Healthcare Conference - Transcripts